MN HF1279

Defines "pharmacy acquisition cost" as the amount a pharmaceutical wholesaler charges for a drug as listed on the pharmacy's invoice, and establishes requirements for pharmacy benefit managers to base reimbursement on this cost or national average drug acquisition cost, whichever is applicable.

Prohibits pharmacy benefit managers from charging pharmacies fees related to claim adjudication, development of claims processing services, or network participation.

Prohibits spread pricing models where pharmacy benefit managers charge plan sponsors a different price than what they pay pharmacies for the same prescription drugs.

Requires pharmacy benefit managers to reimburse independent pharmacies at rates equal to or greater than what they reimburse their own affiliates or subsidiaries for the same drugs on a per-unit basis.

Establishes maximum allowable cost pricing requirements including updating prices at least every seven business days, providing accessible price lists to pharmacies, and creating an appeal process allowing pharmacies to challenge prices below their acquisition costs with decisions required within 30 business days.